ABO and Alzheimer disease: In a hippocampal slice preparation, application of oligomers of Aβ (AβO) increased the expression and activity of KCa3.1; in a mouse model of AD (5×FAD) and in AD patients the increase in expression and activity of KCa3.1 was also observed.